August 14, 2025

Ischaemic cardiovascular risk with allopurinol and protective effect of colchicine in gout: a Dutch nationwide pharmaco-epidemiological study.

View Full Paper

Ask AI

Bookmark

Gout patients prescribed allopurinol showed a significant increase in cardiovascular disease risk post-initiation.
Incidence rate ratios revealed dose-dependent cardiovascular disease risk, especially in the first 90 days after starting allopurinol.
Colchicine use alongside allopurinol was found to attenuate the cardiovascular disease risk in patients.
Discontinuation of allopurinol did not correlate with an increased cardiovascular disease risk, suggesting long-term safety.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Pharmaco-epidemiological study shows allopurinol use increases cardiovascular disease risk in gout patients, indicating colchicine may provide protection.

Cite This Study

Peeters et al. (2025) studied this question.

synapsesocial.com/papers/689fc6852abb084d53ed2406 https://doi.org/10.1093/eurjpc/zwaf513

View Full Paper

Ask AI

Bookmark

Implication

Pharmaco-epidemiological study shows allopurinol use increases cardiovascular disease risk in gout patients, indicating colchicine may provide protection.

Ischaemic cardiovascular risk with allopurinol and protective effect of colchicine in gout: a Dutch nationwide pharmaco-epidemiological study.

Key Points

Discussion

Implication

Cite This Study

Ischaemic cardiovascular risk with allopurinol and protective effect of colchicine in gout: a Dutch nationwide pharmaco-epidemiological study.

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider